← FDA Drug Approvals (Drugs@FDA)
THIOTEPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-03-08
Drug application
- FDA Application #
ANDA214222- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- THIOTEPA
- Generic name
- THIOTEPA
- Active ingredients
- THIOTEPA
- Dosage form
- POWDER
- Route
- INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Dr.Reddy's Laboratories Inc.,
- First approval
- 2021-03-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown